[go: up one dir, main page]

GB2425129B - Cytotrophoblast stem cell - Google Patents

Cytotrophoblast stem cell

Info

Publication number
GB2425129B
GB2425129B GB0606875A GB0606875A GB2425129B GB 2425129 B GB2425129 B GB 2425129B GB 0606875 A GB0606875 A GB 0606875A GB 0606875 A GB0606875 A GB 0606875A GB 2425129 B GB2425129 B GB 2425129B
Authority
GB
United Kingdom
Prior art keywords
stem cell
cytotrophoblast stem
cytotrophoblast
cell
stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0606875A
Other versions
GB0606875D0 (en
GB2425129A (en
Inventor
Harry Moore
Paul Gerskowitch
Rosliah Harun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axordia Ltd
Original Assignee
Axordia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axordia Ltd filed Critical Axordia Ltd
Publication of GB0606875D0 publication Critical patent/GB0606875D0/en
Publication of GB2425129A publication Critical patent/GB2425129A/en
Application granted granted Critical
Publication of GB2425129B publication Critical patent/GB2425129B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0606875A 2005-04-16 2006-04-06 Cytotrophoblast stem cell Expired - Fee Related GB2425129B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0507755.7A GB0507755D0 (en) 2005-04-16 2005-04-16 Cytotrophoblast stem cells

Publications (3)

Publication Number Publication Date
GB0606875D0 GB0606875D0 (en) 2006-05-17
GB2425129A GB2425129A (en) 2006-10-18
GB2425129B true GB2425129B (en) 2008-11-05

Family

ID=34630823

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0507755.7A Ceased GB0507755D0 (en) 2005-04-16 2005-04-16 Cytotrophoblast stem cells
GB0606875A Expired - Fee Related GB2425129B (en) 2005-04-16 2006-04-06 Cytotrophoblast stem cell

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0507755.7A Ceased GB0507755D0 (en) 2005-04-16 2005-04-16 Cytotrophoblast stem cells

Country Status (2)

Country Link
CN (1) CN101218342A (en)
GB (2) GB0507755D0 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103114075B (en) * 2013-01-18 2014-11-12 内蒙古大学 Cattle trophoderm stem cell system establishment method
JP6486948B2 (en) * 2014-01-08 2019-03-20 サムスン ライフ パブリック ウェルフェア ファウンデーション Stem cells derived from pure trophoblast layer and cell therapeutic agent containing the same
CN104946581B (en) * 2015-04-28 2017-10-13 广东温氏食品集团股份有限公司 A special medium and method for cultivating porcine trophoblast stem cells
CN111304156B (en) * 2020-02-20 2025-10-03 南方医科大学南方医院 Induced trophoblast stem cells and preparation method and application thereof
CN116286666B (en) * 2023-05-15 2023-08-04 成都云测医学生物技术有限公司 Trophoblast cell, preparation method and application thereof, and method for amplifying NK cell
CN119351312B (en) * 2024-12-19 2025-03-14 南京医科大学 Organoid capable of simulating uterine spiral arterial remodeling and in-vitro preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031604A1 (en) * 1995-04-07 1996-10-10 The Regents Of The University Of California Antibodies for the detection of hla-g
WO2000017325A1 (en) * 1998-09-23 2000-03-30 Mount Sinai Hospital Trophoblast cell preparations
WO2003078599A2 (en) * 2002-03-15 2003-09-25 Wicell Research Institute, Inc. Method for generating primate trophoblasts
WO2006052646A2 (en) * 2004-11-04 2006-05-18 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
WO2006091766A2 (en) * 2005-02-24 2006-08-31 Jau-Nan Lee Human trophoblast stem cells and use thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031604A1 (en) * 1995-04-07 1996-10-10 The Regents Of The University Of California Antibodies for the detection of hla-g
WO2000017325A1 (en) * 1998-09-23 2000-03-30 Mount Sinai Hospital Trophoblast cell preparations
WO2003078599A2 (en) * 2002-03-15 2003-09-25 Wicell Research Institute, Inc. Method for generating primate trophoblasts
WO2006052646A2 (en) * 2004-11-04 2006-05-18 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
WO2006091766A2 (en) * 2005-02-24 2006-08-31 Jau-Nan Lee Human trophoblast stem cells and use thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Endocrinology (2004), Vol 145, pp 1517-1524, "Trophoblast differentiation in embryoid bodies...", Gerami-Naini et al *
Journal of Clinical Investigation (1997), Vol 99, pp 2139-2151, "Human cytotrophoblasts adopt a...", Zhou et al *
Journal of Immunology (1995); Vol 154, pp 3771-3778, "Human placental HLA-G expression is...", McMaster et al *
Science (1998), Vol 282, pp 2072-2075, "Promotion of trophoblas stem cell...", Tanaka et al *

Also Published As

Publication number Publication date
CN101218342A (en) 2008-07-09
GB0606875D0 (en) 2006-05-17
GB0507755D0 (en) 2005-05-25
GB2425129A (en) 2006-10-18

Similar Documents

Publication Publication Date Title
IL266958A (en) Placental stem cell populations
GB2441530B (en) Stem Cells
GB2437005B (en) Valve
GB0504055D0 (en) Valve
GB0504156D0 (en) Valve
IL215527A (en) Immunoassay methods
GB2425129B (en) Cytotrophoblast stem cell
GB2429261B (en) Valve
GB0503918D0 (en) Cell
EP1934472A4 (en) Slide valve
GB2429263B (en) Valve
GB0519657D0 (en) Valve
GB0511723D0 (en) Placental stem cells
GB0522564D0 (en) Cells
GB0500869D0 (en) Stem cells
GB0511918D0 (en) Valves
GB0521608D0 (en) Novel valve
ZA200508547B (en) Valve
GB0500625D0 (en) Valve
GB0522395D0 (en) Valve
GB0511435D0 (en) Valve
GB0500624D0 (en) Valve
GB0500626D0 (en) Valve
GB0511433D0 (en) Valve
PL374339A1 (en) Valve

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20110324 AND 20110330

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140406